SEC 13F Intelligence

Nan Shan Life Insurance Co., Ltd. / CELG

Nan Shan Life Insurance Co., Ltd.’s Celgene Corp Position

Does Nan Shan Life Insurance Co., Ltd. own Celgene Corp (CELG)? Not currently — the last reported position was 203.3K shares worth $20M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$20M
Q3 2019
Shares
203.3K
% of Portfolio
+0.56%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $18MQ4 ’18Q1 ’19: $25MQ1 ’19Q2 ’19: $24MQ2 ’19Q3 ’19: $20MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019203.3K$20M+0.56%
Q2 2019264.8K$24M+0.63%
Q1 2019264.8K$25M+0.49%
Q4 2018279.8K$18M+0.43%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nan Shan Life Insurance Co., Ltd.’s full portfolio or all institutional holders of CELG.